246 related articles for article (PubMed ID: 28233591)
1. Vessel-sparing Radiotherapy for Localized Prostate Cancer to Preserve Erectile Function: A Single-arm Phase 2 Trial.
Spratt DE; Lee JY; Dess RT; Narayana V; Evans C; Liss A; Winfield R; Schipper MJ; Lawrence TS; McLaughlin PW
Eur Urol; 2017 Oct; 72(4):617-624. PubMed ID: 28233591
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer.
Davis JW; Chang DW; Chevray P; Wang R; Shen Y; Wen S; Pettaway CA; Pisters LL; Swanson DA; Madsen LT; Huber N; Troncoso P; Babaian RJ; Wood CG
Eur Urol; 2009 May; 55(5):1135-43. PubMed ID: 18783876
[TBL] [Abstract][Full Text] [Related]
3. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
[TBL] [Abstract][Full Text] [Related]
4. Erectile function after stereotactic body radiotherapy for localized prostate cancer.
Dess RT; Hartman HE; Aghdam N; Jackson WC; Soni PD; Abugharib AE; Suy S; Desai NB; Zumsteg ZS; Mehra R; Morgan TM; Feng FY; Hamstra DA; Schipper MJ; Collins SP; Spratt DE
BJU Int; 2018 Jan; 121(1):61-68. PubMed ID: 28710895
[TBL] [Abstract][Full Text] [Related]
5. Persistent erectile dysfunction following radical prostatectomy: the association between nerve-sparing status and the prevalence and chronology of venous leak.
Tal R; Valenzuela R; Aviv N; Parker M; Waters WB; Flanigan RC; Mulhall JP
J Sex Med; 2009 Oct; 6(10):2813-9. PubMed ID: 19686421
[TBL] [Abstract][Full Text] [Related]
6. Prospective comprehensive assessment of sexual function after retropubic non nerve sparing radical prostatectomy for localized prostate cancer.
Trinchieri A; Nicola M; Masini F; Mangiarotti B
Arch Ital Urol Androl; 2005 Dec; 77(4):219-23. PubMed ID: 16444937
[TBL] [Abstract][Full Text] [Related]
7. Effect of Prostate Cancer Severity on Functional Outcomes After Localized Treatment: Comparative Effectiveness Analysis of Surgery and Radiation Study Results.
Tyson MD; Koyama T; Lee D; Hoffman KE; Resnick MJ; Wu XC; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Paddock LE; Stroup A; Chen V; Conwill R; McCollum D; Penson DF; Barocas DA
Eur Urol; 2018 Jul; 74(1):26-33. PubMed ID: 29501451
[TBL] [Abstract][Full Text] [Related]
8. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
[TBL] [Abstract][Full Text] [Related]
9. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo.
Pavlovich CP; Levinson AW; Su LM; Mettee LZ; Feng Z; Bivalacqua TJ; Trock BJ
BJU Int; 2013 Oct; 112(6):844-51. PubMed ID: 23937708
[TBL] [Abstract][Full Text] [Related]
10. Vessel-sparing prostate radiotherapy: dose limitation to critical erectile vascular structures (internal pudendal artery and corpus cavernosum) defined by MRI.
McLaughlin PW; Narayana V; Meirovitz A; Troyer S; Roberson PL; Gonda R; Sandler H; Marsh L; Lawrence T; Kessler M
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):20-31. PubMed ID: 15629590
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy and satisfaction profile, between penile prosthesis implantation and oral PDE5 inhibitor tadalafil therapy, in men with nerve-sparing radical prostatectomy erectile dysfunction.
Megas G; Papadopoulos G; Stathouros G; Moschonas D; Gkialas I; Ntoumas K
BJU Int; 2013 Jul; 112(2):E169-76. PubMed ID: 23253640
[TBL] [Abstract][Full Text] [Related]
12. Ten-year outcomes of sexual function after radical prostatectomy: results of a prospective longitudinal study.
Sivarajan G; Prabhu V; Taksler GB; Laze J; Lepor H
Eur Urol; 2014 Jan; 65(1):58-65. PubMed ID: 24007711
[TBL] [Abstract][Full Text] [Related]
13. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function.
Mulhall JP; Parker M; Waters BW; Flanigan R
BJU Int; 2010 Jan; 105(1):37-41. PubMed ID: 19659465
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.
Cathala N; Mombet A; Sanchez-Salas R; Rozet F; Barret E; Giuliano F; Galiano M; Prapotnich D; Kazzazi A; Djavan B; Jaffe J; Cathelineau X; Vallancien G
Can J Urol; 2012 Aug; 19(4):6328-35. PubMed ID: 22892254
[TBL] [Abstract][Full Text] [Related]
15. Optimal strategy for penile rehabilitation after robot-assisted radical prostatectomy based on preoperative erectile function.
Basal S; Wambi C; Acikel C; Gupta M; Badani K
BJU Int; 2013 Apr; 111(4):658-65. PubMed ID: 23186312
[TBL] [Abstract][Full Text] [Related]
16. End-to-side Somatic-to-autonomic Nerve Grafting to Restore Erectile Function and Improve Quality of Life After Radical Prostatectomy.
Reece JC; Dangerfield DC; Coombs CJ
Eur Urol; 2019 Aug; 76(2):189-196. PubMed ID: 30955973
[TBL] [Abstract][Full Text] [Related]
17. Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapy.
Lee JY; Spratt DE; Liss AL; McLaughlin PW
Lancet Oncol; 2016 May; 17(5):e198-208. PubMed ID: 27301047
[TBL] [Abstract][Full Text] [Related]
18. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
Raina R; Pahlajani G; Agarwal A; Zippe CD
BJU Int; 2007 Dec; 100(6):1317-21. PubMed ID: 17850385
[TBL] [Abstract][Full Text] [Related]
19. Short- and Long-term Functional Outcomes and Quality of Life after Radical Prostatectomy: Patient-reported Outcomes from a Tertiary High-volume Center.
Pompe RS; Tian Z; Preisser F; Tennstedt P; Beyer B; Michl U; Graefen M; Huland H; Karakiewicz PI; Tilki D
Eur Urol Focus; 2017 Dec; 3(6):615-620. PubMed ID: 28869202
[TBL] [Abstract][Full Text] [Related]
20. Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer.
Mantz CA; Song P; Farhangi E; Nautiyal J; Awan A; Ignacio L; Weichselbaum R; Vijayakumar S
Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):551-7. PubMed ID: 9112452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
